Literature DB >> 7351603

Neonatal hypermagnesemia: effect on parathyroid hormone and calcium homeostasis.

E F Donovan, R C Tsang, J J Steichen, R J Strub, I W Chen, M Chen.   

Abstract

Twenty pre-eclamptic mothers treated with MgSO4 and their newborn infants were studied prospectively to determine the clinical and biochemical effects of hypermagnesemia. Maternal serum magnesium concentration rose to 4.4 mg/dl at delivery and was accompanied by a fall in maternal serum calcium concentration during labor. Neonatal serum Mg concentration remained elevated for the first 72 hours of life (mean at 72 hours = 3.0 mg/dl). Serum Mg concentration was higher in premature infants and in babies with birth asphyxia and/or hypotonia. Serum Ca concentration was higher and serum PTH was lower in hypermagnesemic study infants when compared to a retrospectively selected, matched froup of control infants. We speculate that elevated serum Mg values in these infants result in a shift of Ca from bone to plasma, and that elevated Mg and Ca concentrations further suppress neonatal parathyroid function.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7351603     DOI: 10.1016/s0022-3476(80)80835-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  8 in total

1.  Effects of the intravenous administration of magnesium sulfate on corrected serum calcium level and nephrogenous cyclic AMP excretion in normal human subjects.

Authors:  K Suzuki; K Nonaka; N Kono; K Ichihara; Y Fukumoto; Y Inui; J Miyagawa; T Onishi; C Hayashi; S Tarui
Journal:  Calcif Tissue Int       Date:  1986-11       Impact factor: 4.333

2.  The effect of intravenous magnesium sulphate on parathyroid function in primary hyperparathyroidism.

Authors:  I R Gough; G A Balderson; H M Lloyd; J Galligan; D Willgoss; B G Fryar
Journal:  World J Surg       Date:  1988-08       Impact factor: 3.352

3.  Severe hypermagnesaemia due to magnesium sulphate enemas in patients with hepatic coma.

Authors:  P O Collinson; A K Burroughs
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-18

4.  CaSR-mediated interactions between calcium and magnesium homeostasis in mice.

Authors:  Stephen J Quinn; Alex R B Thomsen; Ogo Egbuna; Jian Pang; Khanjan Baxi; David Goltzman; Martin Pollak; Edward M Brown
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-01-29       Impact factor: 4.310

5.  Transient hypercalcemia followed by hypocalcemia in a preterm infant after maternal magnesium sulfate therapy.

Authors:  Takahiro Tominaga; Kazushige Ikeda; Midori Awazu
Journal:  Clin Pediatr Endocrinol       Date:  2021-12-26

Review 6.  Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review.

Authors:  Emily S Bain; Philippa F Middleton; Caroline A Crowther
Journal:  BMC Pregnancy Childbirth       Date:  2013-10-21       Impact factor: 3.007

7.  Assessment of serum magnesium levels and its outcome in neonates of eclamptic mothers treated with low-dose magnesium sulfate regimen.

Authors:  Monalisa Das; Patralekha Ray Chaudhuri; Badal C Mondal; Sukumar Mitra; Debasmita Bandyopadhyay; Sushobhan Pramanik
Journal:  Indian J Pharmacol       Date:  2015 Sep-Oct       Impact factor: 1.200

8.  Autism Spectrum Disorder and Neonatal Serum Magnesium Levels in Preterm Infants.

Authors:  Amanda V Bakian; Deborah A Bilder; E Kent Korgenski; Joshua L Bonkowsky
Journal:  Child Neurol Open       Date:  2018-09-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.